A carregar...
Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
Several clinical trials have demonstrated the efficacy of lytic therapies targeting B cells in the treatment of relapsing multiple sclerosis (MS). More modest efficacy has been noted in the primary progressive subtype of MS. Clinical success has increased interest in the role of B cells in the patho...
Na minha lista:
| Publicado no: | Front Neurol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7862116/ https://ncbi.nlm.nih.gov/pubmed/33551958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.595547 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|